Fong Bryant 4
4 · ADMA BIOLOGICS, INC. · Filed Aug 23, 2023
Insider Transaction Report
Form 4
Fong Bryant
Director
Transactions
- Sale
Common Stock
2023-08-22$3.87/sh−1,433,304$5,544,737→ 0 total(indirect: See footnote)
Holdings
- 59,901
Common Stock
Footnotes (3)
- [F1]Reflects the weighted average price of sales on August 22, 2023. The shares were sold in multiple transactions at prices ranging from $3.81 to $3.99, inclusive.
- [F2]Represents shares sold by Biomark Capital Fund ("Biomark Capital"). Mr. Fong is a Managing Director and General Partner at Biomark Capital and may have been deemed the beneficial owner of such shares.
- [F3]Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date; and (ii) 34,086 shares of common stock owned by the reporting person.